Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Defining Fundamental B Cell-Subset Dysfunction in Myeloma

Rao H Prabhala, PhD, Srikanth Talluri, PhD, Megan Stekla, BS, Andreea Negroiu, MD, Michael Buonopane, BS, Kevin LaBlanc, BS, Alex Heubeck, BS, Mariateresa Fulciniti, PhD, Kenneth Anderson, MD, Nikhil Munshi, MD

Blood (2016) 128 (22): 2085.

https://doi.org/10.1182/blood.V128.22.2085.2085

Published: 2016

Journal Articles

p21-Associated Kinase 4 (PAK4) Addiction in Multiple Myeloma: A Potential Therapeutic Application with Enhanced Activity in FGFR3 Expressing Myeloma

Mariateresa Fulciniti, PhD, Joaquin Martinez Lopez, MD PhD, William Senapedis, PhD, Stefania Oliva, MD, Raphaël Szalat, MD, Mehmet K. Samur, PhD, Rao H Prabhala, PhD, Kenneth C. Anderson, MD, Nikhil C Munshi, MD

Blood (2016) 128 (22): 3302.

https://doi.org/10.1182/blood.V128.22.3302.3302

Published: 2016

Journal Articles

Evaluating the Efficacy and Toxicity of Two Lenalidomide Dose Regimens for the Treatment of Older Relapsed Multiple Myeloma Patients with Co-Morbidities: A Multi-Site Study at the Veteran's Administration Hospitals

Sarvari V Yellapragada, MD, Shayna Sarosiek, MD, Neelima D Prabhala, B.A., Mehmet Kemalsamur, PhD, Antoun Houranieh, RPh., M.S., PhD, Saulius Girnius, MD, Praveen Tumula, MD, Suman Kambhampati, MD, Nirmala Bhoopalam, MD, Rao H Prabhala, PhD, David Roodman, MD, PhD, Alan Lichtenstein, MD, Nikhil C Munshi, MD

Blood (2015) 126 (23): 5370.

https://doi.org/10.1182/blood.V126.23.5370.5370

Published: 2015

Journal Articles

IL-17A-Mediated Notch Signaling in Multiple Myeloma

Rao H. Prabhala, PhD, Teru Hideshima, MD PhD, Mariateresa Fulciniti, PhD, Sophia Adamia, PhD, Rajya Lakshmi Bandi, BS, Puru Nanjappa, MS, Kenneth C. Anderson, Nikhil C. Munshi, MD

Blood (2014) 124 (21): 3434.

https://doi.org/10.1182/blood.V124.21.3434.3434

Published: 2014

Journal Articles

Mir-23b Plays a Critical Role As a Tumor Suppressor miRNA In Multiple Myeloma

Mariateresa Fulciniti, PhD, Nicola Amodio, PhD, Rajya Bandi, Rao H. Prabhala, Ph.D., Sophia Adamia, PhD, Teresa Calimeri, MD, Lavinia Biamonte, PhD, Marzia Leotta, MD, Kenneth C. Anderson, MD, Pierfrancesco Tassone, MD, Munshi C Nikhil, MD

Blood (2013) 122 (21): 122.

https://doi.org/10.1182/blood.V122.21.122.122

Published: 2013

Journal Articles

Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target

Rao H. Prabhala, Ph.D., Mariateresa Fulcinitti, PhD, Dheeraj Pelluru, PhD, Harsha K. Prabhala, MS, Naim Rashid, PhD, Adam Sperling, MD, PhD, Puru Nanjappa, MS, Saem Lee, B.A., Andreea Negroiu, MD, Suzan Lazo-Kallanian, BS, Aditya Munshi, MD, Paul G. Richardson, MD, John Daley, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 3113.

https://doi.org/10.1182/blood.V122.21.3113.3113

Published: 2013

Journal Articles

Sp1 Inhibition Affects Cell Growth and Survival In Waldenstrom’s Macroglobulinemia Through a MYD88-Independent Pathway

Mariateresa Fulciniti, PhD, Rajya Bandi, Nicola Amodio, PhD, Rao H. Prabhala, Ph.D., Mansa Munshi, PhD, Lian Xu, Guang Yang, PhD, Zachary Hunter, Kenneth C. Anderson, MD, Steven Peter Treon, MD, MA, PhD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 3065.

https://doi.org/10.1182/blood.V122.21.3065.3065

Published: 2013

Journal Articles

Reprogramming Aberrant B Cell-Subsets to Improve Immune Function in Multiple Myeloma

Rao H. Prabhala, Ph.D., Andreea Negroiu, MD, Saem Lee, B.A., Mariateresa Fulciniti, PhD, Puru Nanjappa, Ms, Harsha K. Prabhala, Adithya Munshi, MD, Irene M. Ghobrial, MD, Paul G. Richardson, MD, Jacob Laubach, MD, John Daley, PhD, Steven P. Treon, M.D., Ph.D., Charles Allam, MD, Kenneth C. Anderson, MD, Nikhil C Munshi, MD

Blood (2012) 120 (21): 3986.

https://doi.org/10.1182/blood.V120.21.3986.3986

Published: 2012

Journal Articles

Induction of T Cell Immunity Using a Multipeptide Cocktail Containing XBP1, CD138 and CS1 Peptides in Smoldering Multiple Myeloma

Jooeun Bae, PhD, Rao H. Prabhala, Ph.D., Weihua Song, MD, Yu-Tzu Tai, PhD, Kenneth C. Anderson, Nikhil C Munshi, MD

Blood (2012) 120 (21): 5039.

https://doi.org/10.1182/blood.V120.21.5039.5039

Published: 2012

Journal Articles

Targeting Sp1 Transactivation In Waldenstrom's Macroglobulinemia: a Novel Therapeutic Option

Mariateresa Fulciniti, Samir B. Amin, MBBS, Varuna Mohan, Guang Yang, MD, Puru Nanjappa, Pierfrancesco Tassone, Rao H Prabhala, Ph.D., Li Cheng, Kenneth C. Anderson, Steven P. Treon, MD, PhD, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 120.

https://doi.org/10.1182/blood.V116.21.120.120

Published: 2010

Journal Articles

Perifosine Affects Phenotype and Function of Human Myeloid Dendritic Cells

Weihua Song, MD, Teru Hideshima, Yu-Tzu Tai, PhD, Rao H Prabhala, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 3911.

https://doi.org/10.1182/blood.V116.21.3911.3911

Published: 2010

Journal Articles

Interleukin-17 and T H 17 Pathway Supports Waldenstrom's Macroglobulinemia Cell-Growth: Potential Therapeutic Implications

Rao H Prabhala, Ph.D., Dheeraj Pelluru, PhD, Mariateresa Fulciniti, PhD, Puru Nanjappa, MS, Christine Pai, BS, Saem Lee, B.A., Nithya Prabhala, John Daley, PhD, Steven P. Treon, MD, PhD, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 446.

https://doi.org/10.1182/blood.V116.21.446.446

Published: 2010

Journal Articles

Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma

Rao H Prabhala, PH.D., Mariateresa Fulciniti, PhD, Dheeraj Pelluru, PhD, Puru Nanjappa, MS, Christine Pai, BS, Saem Lee, B.A., Nithya Prabhala, Weihua Song, MD, Constantine S. Mitsiades, MD, PhD, Konstantinos Lefkimmiatis, PhD, Yu-Tzu Tai, PhD, Irene Ghobrial, MD, Paul Richardson, MD, John Daley, Kenneth C. Anderson, MD, Seth Ettenberg, Franco Di Padova, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 456.

https://doi.org/10.1182/blood.V116.21.456.456

Published: 2010

Journal Articles

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Nikhil C. Munshi, M.D., Saem Lee, B.A., Suman Kambhampati, M.D., Abid Mohiuddin, M.D., Michal Rose, M.D., Caroline Behler, M.D., Andrew Han, B.A., Yvonne Efebera, M.D., Antoun Houranieh, RPh., M.S., Ph.D., Mary T. Brophy, M.D., Abraham Zimelman, M.D., Rao H Prabhala, Ph.D., Hussain I. Saba, M.D, Ph.D, Catherine Klein, M.D., Paulette Mehta, M.D, MPH, Teresa Hayes, M.D., David Roodman, M.D, Ph.D, Alan K. Lichtenstein, M.D.

Blood (2010) 116 (21): 3061.

https://doi.org/10.1182/blood.V116.21.3061.3061

Published: 2010

Journal Articles

Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

Rao H. Prabhala, Dheeraj Pelluru, Mariateresa Fulciniti, Harsha K. Prabhala, Puru Nanjappa, Weihua Song, Christine Pai, Samir Amin, Yu-Tzu Tai, Paul G. Richardson, Irene M. Ghobrial, Steven P. Treon, John F. Daley, Kenneth C. Anderson, Jeffery L. Kutok, Nikhil C. Munshi

Blood (2010) 115 (26): 5385–5392.

https://doi.org/10.1182/blood-2009-10-246660

Published: 2010

Journal Articles

The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome

James J. Driscoll, Dheeraj Pelluru, Konstantinos Lefkimmiatis, Mariateresa Fulciniti, Rao H. Prabhala, Philip R. Greipp, Bart Barlogie, Yu-Tzu Tai, Kenneth C. Anderson, John D. Shaughnessy, Jr, Christina M. Annunziata, Nikhil C. Munshi

Blood (2010) 115 (14): 2827–2834.

https://doi.org/10.1182/blood-2009-03-211045

Published: 2010

Includes: Supplemental data

Journal Articles

Lack of Response to Vaccination in MGUS and Stable Myeloma.

Rao H Prabhala, PhD, Yvonne A Efebera, MD, Saem Lee, Andrew J Han, Dheeraj Pelluru, Puru Nanjappa, MS, Samir Amin, Christine Pai, Irene Ghobrial, M.D., Robert L Schlossman, M.D., Ph.D., Jacob Laubach, Mariateresa Fulciniti, Paul Richardson, M.D., Ph.D., Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2009) 114 (22): 1852.

https://doi.org/10.1182/blood.V114.22.1852.1852

Published: 2009

Journal Articles

Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance

Simona Blotta, Pierfrancesco Tassone, Rao H. Prabhala, Piersandro Tagliaferri, David Cervi, Samir Amin, Jana Jakubikova, Yu-Tzu Tai, Klaus Podar, Constantine S. Mitsiades, Alessandro Zullo, Brunella Franco, Kenneth C. Anderson, Nikhil C. Munshi

Blood (2009) 114 (15): 3276–3284.

https://doi.org/10.1182/blood-2009-04-219436

Published: 2009

Journal Articles

Myeloma Microenvironment Controls T Regulatory Cell Activity: Potential Target for Therapeutic Interventions.

Rao H. Prabhala, PhD, Paola Neri, MD, Mariateresa Fulciniti, PhD, Vanessa A. Therrien, Vidit Munshi, James J. Driscoll, MD,PhD, Masood A. Shammas, PhD, Teru Hideshima, MD,PhD, John F. Daley, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 659.

https://doi.org/10.1182/blood.V108.11.659.659

Published: 2006

Journal Articles

Physical and Functional Association of the MRN Complex with Human Telomerase in Multiple Myeloma.

James J. Driscoll, MD, PhD, Robert C. Bertheau, Masood A. Shammas, PhD, Rao H. Prabhala, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 5076.

https://doi.org/10.1182/blood.V108.11.5076.5076

Published: 2006

NARROW

Defining Fundamental B Cell-Subset Dysfunction in Myeloma

p21-Associated Kinase 4 (PAK4) Addiction in Multiple Myeloma: A Potential Therapeutic Application with Enhanced Activity in FGFR3 Expressing Myeloma

Evaluating the Efficacy and Toxicity of Two Lenalidomide Dose Regimens for the Treatment of Older Relapsed Multiple Myeloma Patients with Co-Morbidities: A Multi-Site Study at the Veteran's Administration Hospitals

IL-17A-Mediated Notch Signaling in Multiple Myeloma

Mir-23b Plays a Critical Role As a Tumor Suppressor miRNA In Multiple Myeloma

Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target

Sp1 Inhibition Affects Cell Growth and Survival In Waldenstrom’s Macroglobulinemia Through a MYD88-Independent Pathway

Reprogramming Aberrant B Cell-Subsets to Improve Immune Function in Multiple Myeloma

Induction of T Cell Immunity Using a Multipeptide Cocktail Containing XBP1, CD138 and CS1 Peptides in Smoldering Multiple Myeloma

Targeting Sp1 Transactivation In Waldenstrom's Macroglobulinemia: a Novel Therapeutic Option

Perifosine Affects Phenotype and Function of Human Myeloid Dendritic Cells

Interleukin-17 and T H 17 Pathway Supports Waldenstrom's Macroglobulinemia Cell-Growth: Potential Therapeutic Implications

Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome

Lack of Response to Vaccination in MGUS and Stable Myeloma.

Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance

Myeloma Microenvironment Controls T Regulatory Cell Activity: Potential Target for Therapeutic Interventions.

Physical and Functional Association of the MRN Complex with Human Telomerase in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only